Mifepristone (RU-486) and limits to abortion

David van Gend
Med J Aust 2006; 184 (11): .
Published online: 5 June 2006

In reply: Belton is correct that “safety and efficacy of medications” is a matter for the Therapeutic Goods Association. The dispute was whether such limited criteria can meaningfully assess a drug designed to take life.

  • David van Gend

  • World Federation of Doctors Who Respect Human Life, Toowoomba, QLD.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.